ESR1 and breast cancer: A single-cell RNA-seq analysis comparing primary and metastatic ER+ breast cancers revealed an enrichment of chemokine ligand 2-positive (CCL2+; encoded by CCL2) tumor-associated macrophages, FOXP3+ regulatory T cells, and exhausted CD8+ T cells in metastatic lesions.